Published in J Clin Microbiol on June 01, 1985
Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res (2007) 2.67
Combined effect of infection and heavy wrapping on the risk of sudden unexpected infant death. Arch Dis Child (1992) 2.49
Laboratory diagnostics of botulism. Clin Microbiol Rev (2006) 2.32
Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments. J Clin Microbiol (2005) 1.29
First case of infant botulism caused by Clostridium baratii type F in California. J Clin Microbiol (2005) 1.00
Update: infant botulism. Clin Microbiol Rev (1996) 0.96
Detection and confirmation of Clostridium botulinum in water used for cooling at a plant producing low-acid canned foods. Appl Environ Microbiol (2010) 0.96
Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med (1976) 4.85
Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet (1976) 4.07
Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. Appl Microbiol (1971) 3.38
Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA (1977) 2.71
Examination of prepared foods in plastic packages for Clostridium botulinum. Appl Microbiol (1967) 2.24
Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines. Antimicrob Agents Chemother (1975) 2.22
Selective medium for isolation of Clostridium botulinum from human feces. J Clin Microbiol (1981) 2.16
Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin. Appl Environ Microbiol (1977) 1.62
Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis (1980) 1.37
Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism. J Clin Microbiol (1982) 1.31
Experimental botulism in chickens: the cecum as the site of production and absorption of botulinum toxin. Jpn J Med Sci Biol (1978) 1.29
Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. Antimicrob Agents Chemother (1980) 1.26
Diagnosis and management of infant botulism. Am J Dis Child (1979) 1.16
Botulism in New South Wales, 1980-1981. Med J Aust (1983) 0.89
Infant botulism. A Pan-Pacific perspective. Med J Aust (1983) 0.81
Infant botulism. Identification of Clostridium botulinum and its toxins in faeces. Lancet (1976) 4.07
Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA (1977) 3.05
Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet (1978) 2.60
Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis (1989) 2.38
Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38
The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J (1971) 2.04
The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97
The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood (1975) 1.87
Infant botulism. Annu Rev Med (1980) 1.76
Honey and other environmental risk factors for infant botulism. J Pediatr (1979) 1.68
Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol (1977) 1.56
Clinical trial of botulism immune globulin for infant botulism. West J Med (1991) 1.45
Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism. J Infect Dis (1980) 1.37
Quality control of individual components used in Middlebrook 7H10 medium for mycobacterial susceptibility testing. J Clin Microbiol (1988) 1.32
Clostridium botulinum type F: isolation from venison jerky. Appl Microbiol (1972) 1.31
Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res (1974) 1.26
Use of immunofluorescence to identify Clostridium botulinum types A, B, and E. Public Health Rep (1967) 1.26
Blood platelet nucleotides in man and other species. Nature (1969) 1.24
Infant botulism: anticipating the second decade. J Infect Dis (1986) 1.21
Detection and determination of adenosine diphosphate and related substances in plasma. Biochem J (1966) 1.20
The platelet defect associated with albumism. Br J Haematol (1972) 1.17
Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol (1975) 1.16
Diagnosis and management of infant botulism. Am J Dis Child (1979) 1.16
The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem J (1967) 1.09
A second case of infant botulism type F caused by Clostridium baratii. Pediatr Infect Dis J (1995) 1.08
2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest (1983) 1.07
Finding sutures. Plast Reconstr Surg (1989) 1.07
The clinical spectrum of infant botulism. Rev Infect Dis (1980) 1.05
The interaction of bovine factor VIII with human platelets. J Clin Invest (1975) 1.04
Inhibition by ADP of prostaglandin induced accumulation of cyclic AMP in intact human platelets. J Cyclic Nucleotide Res (1981) 1.03
Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Biochemistry (1982) 1.03
Food and environmental aspects of infant botulism in California. Rev Infect Dis (1980) 1.00
Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis. J Pediatr (1984) 1.00
Changes in the adenylate energy charge in human blood platelets induced by adenosine diphosphate. Nat New Biol (1973) 0.97
Potentiation of the inhibitory effect of adenosine on platelet aggregation by drugs that prevent its uptake. J Physiol (1969) 0.93
Infant botulism in 1931. Discovery of a misclassified case. Am J Dis Child (1979) 0.91
Nucleotide and serotonin metabolism in platelets with defective secondary aggregation. Blood (1974) 0.90
Isolation of Clostridium botulinum from Honey. J Clin Microbiol (1979) 0.89
Breast feeding and toxigenic intestinal infections: missing links in crib death? Rev Infect Dis (1984) 0.88
Distribution of HIV type 1 infection in childbearing women in California. Am J Public Health (1992) 0.88
Identification of a receptor for ADP on blood platelets by photoaffinity labelling. Biochem J (1993) 0.88
The platelet defect associated with albinism. Ann N Y Acad Sci (1972) 0.87
The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation. Br J Haematol (1975) 0.86
Potentiation of platelet aggregation by adrenaline. J Physiol (1967) 0.85
Novel structural elements within the nonproteolytic clostridium botulinum type F toxin gene cluster. Appl Environ Microbiol (2010) 0.85
Commentary: where Marco Polo meets Meckel: type E botulism from Clostridium butyricum. Clin Infect Dis (1999) 0.85
Malondialdehyde production by platelets during secondary aggregation. Thromb Haemost (1977) 0.82
Infant botulism. A Pan-Pacific perspective. Med J Aust (1983) 0.81
Botulism immune globulin for infant botulism arrives--one year and a Gulf War later. West J Med (1992) 0.81
Laboratory aspects of infant botulism in California. Rev Infect Dis (1980) 0.81
The control of platelet responsiveness by agents that influence cyclic AMP metabolism. Ann N Y Acad Sci (1972) 0.81
Initial biochemical responses of platelets to stimulation. Ciba Found Symp (1975) 0.81
Protective role of human milk against sudden death from infant botulism. J Pediatr (1982) 0.80
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase. Biochem J (1970) 0.80
Characterization of extracellular nucleotide-induced Mac-1 (alphaM beta2 integrin) surface expression on peripheral blood leukocytes. Biochem Biophys Res Commun (1997) 0.79
Identification of two distinct adenosine diphosphate receptors in human platelets. Trans Assoc Am Physicians (1980) 0.78
Extreme potency of botulinum toxin. Lancet (2000) 0.78
Distribution of phosphatidylethanolamine arachidonic acid in platelet membranes. Biochim Biophys Acta (1981) 0.78
Honey, infant botulism and the sudden infant death syndrome. West J Med (1980) 0.77
Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression. Blood (1998) 0.77
The large intestine as the site of Clostridium botulinum colonization in human infant botulism. J Infect Dis (1987) 0.76
Effects of Clostridium botulinum toxins on infant and adult mice. Appl Environ Microbiol (1982) 0.75
Evaluation of the Minitek system for characterization of Bacillus species. Appl Environ Microbiol (1987) 0.75
Characterization of P2 purinergic receptors on human erythro leukemia cells. J Recept Signal Transduct Res (1997) 0.75
Response to letters on infant botulism. Pediatrics (1982) 0.75
Depletion of platelet amine storage granules by the antithrombotic agent, suloctidil. Thromb Haemost (1977) 0.75
Pharmacology of the inhibition of platelet aggregation. Bull Schweiz Akad Med Wiss (1973) 0.75
Effects of drugs on blood platelets. Br J Haematol (1969) 0.75
Factor VIII-induced superaggregation of human platelets. Blood (1982) 0.75
Letter: Starch emboli in transplanted kidneys. Lancet (1974) 0.75
Botulism in the United States, 1976. J Infect Dis (1977) 0.75
Mapping of the P2U purinergic receptor gene to human chromosome 11q 13.5-14.1. Somat Cell Mol Genet (1996) 0.75
Guanidine in botulism. JAMA (1979) 0.75